Profile
Michael K.
Inouye served as Senior Vice President-Commercial Operations at Telik, Inc. from 2006 to 2007, Senior VP-Corporate & Commercial Development at Pharmacyclics LLC in 2008, and Independent Director at Pharmasset, Inc. from 2005 to 2012.
In terms of education, he received an undergraduate degree from the University of California, Davis and an MBA from California State Polytechnic University (Pomona).
Former positions of Michael K. Inouye
| Companies | Position | End |
|---|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Director/Board Member | 2012-01-11 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 2008-01-31 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Corporate Officer/Principal | 2007-01-31 |
Training of Michael K. Inouye
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California State Polytechnic University (Pomona)
California State Polytechnic University (Pomona) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Michael K. Inouye
















